Universitaetsmedizin Greifswald KöR — Clinical Trial Site

102 Registered trials

49 Currently recruiting

Organisation

Universitaetsmedizin Greifswald KöR

Location

Greifswald, Germany

Identifier

ORG-100010701

Address

Sauerbruchstrasse, 81377, Germany

Departments

"Hämatologie,Onkologie, Transplantationszentrum"
#2203: Klinik und Poliklinik für Neurologie
276001; Zentrum für Innere Medizin, Lungenheilkunde und Infektionskrankheiten
276003; Klinik und Poliklinik für Innere Medizin C
276003: Klinik und Poliklinik für Neurologie
276003:Klinik und Poliklinik für Neurologie
7109:Klinik und Poliklinik für Neurologie
Abt. Pädiatrische Onkologie und Hämatologie
Abteilung für Anästhesiologie
Clinic and policlinic of Ophthalmology
Clinic and Polyclinic for Internal Medicine B
Clinic for Neurology
Department of Internal Medicine C - Hematology, Oncology and Stem Cell Translantation
Department of Internal Medicine C, Hematology/Oncology
Department of Internal Medicine, Respiratory Medicine and Infectious Diseases
Department of Pediatrics, Pediatric Hematology and Oncology/BMT
Hämatologie und Onkologie
Hematology
Hematology and Oncology
HNO
Innere Medizin C
Innere Medizin C Abt. Haematologie / Onkologie
Innere Medizin C, Hämatologie, Onkologie/Transplantationszentrum
Institute for Hygiene and Environmental Medicine
Internal Medicine A
Internal Medicine, Respiratory Medicine and Infectious Diseases
Klinik & Poliklinik für Innere Medizin C
Klinik für Anästhesie, Intensiv-, Notfall- und Schmerzmedizin
Klinik für Innere Medizin A
Klinik für Innere Medizin C
Klinik für Innere Medizin C / Hämatologie/Onkologie/Transplantationszentrum
Klinik für Innere Medizin C Hämatologie und Onkologie, Transplantationszentrum, Palliativmedizin
Klinik für Kinder- und Jugendmedizin
Klinik für Kinder- und Jugendmedizin, Abteilung für päd. Hämatolgie und Onkologie
Klinik für Kinder- und Jugendmedizin, Abteilung Neuropädiatrie und Stoffwechselerkrankungen
Klinik für Neurologie
Klinik Innere Medizin C / Hämatologie und Onkologie
Klinik u. Poliklinik für Allgemeine Chirurgie, Viszeral-, Thorax- u. Gefäßchirurgie
Klinik und Poliklinik für Allgemeine Chirurgie, Viszeral-, Thorax- und Gefäßchirurgie
Klinik und Poliklinik für Augenheilkunde
Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde, Kopf-und Halschirurgie
Klinik und Poliklinik für Hals-, Nasen-, Ohrenkrankheiten, Kopf- und Halschirurgie
Klinik und Poliklinik für Hautkrankheiten
Klinik und Poliklinik für Innere Medizin
Klinik und Poliklinik für Innere Medizin A
Klinik und Poliklinik für Innere Medizin B
Klinik und Poliklinik für Innere Medizin B Innere Medizin, Pneumologie, Internistische
Klinik und Poliklinik für Innere Medizin B Innere Medizin, Pneumologie
Klinik und Poliklinik für Innere Medizin C
Klinik und Poliklinik für Innere Medizin C, Hämatologie und Onkologie, Transplantationsmed
Klinik und Poliklinik für Innere Medizin II - Pneumologie/Infektiologie
Klinik und Poliklinik für Innere Medizin III, Hämatologie/Onkologie
Klinik und Poliklinik für Kinder und Jugendmedizin - Pädiatrische Onkologie und Hämatologie
Klinik und Poliklinik für Kinder- und Jugendmedizin
Klinik und Poliklinik für Kinder- und Jugendmedizin Abt. Pädiatrische Onkologie und Hämatologie
Klinik und Poliklinik für Neorologie
Klinik und Poliklinik für Neurologie
Klinik und Poliklinik für Neurologie, Ferdinand-Sauerbruch Straße
Klinik und Poliklinik für Neuroloie
N/A
Neurology
Otorhinolaryngology, Head and Neck Surgery
Päd. Onkologie und Hämatologie
Pädiatrische Hämatologie und Onkologie
Pädiatrische Onkologie und Hämatologie
Paedriatrics, Department of Oncology and Hematology
Pediatric hematology and oncology
Physical and Rehabilitation Medicine
Universitätsmedizin Greifswald Klinik für Innere Medizin C, Hämatologie und Onkologie
Zentrum für Innere Medizin B - Pneumologie/Infektiologie
Zentrum für Innere Medizin B Pneumologie
Zentrum für Innere Medizin B Pneumologie/Infektiologie

Clinical trials at this site (102)

Search interface

A Study of Vepugratinib (LY3866288) in Participants with Cancer in the Urinary Tract ( FORAGER-2 ) Pending

2025-522855-25-00 Carcinoma, Transitional Cell 5
Phase Ib Dose-Ranging Study of the Safety, PK, PD & Efficacy of the Activin Signaling Inhibitor HS235 vs placebo added to background therapy… Pending

2025-523010-89-00 Pulmonary arterial hypertension 3
A Phase 3 Study of Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis Pending

2025-524316-11-00 Primary Progressive Multiple Sclerosis (PPMS) 5
Phase 2 Study of REGN13335 in Adult Participants with Pulmonary Arterial Hypertension (PAH) Recruiting

2024-514754-79-00 Pulmonary Arterial Hypertension (PAH) 4 2026-05-06
A clinical study to test how safe and effective a new inhaled treatment (called L606) is for people with high blood pressure in the lungs du… Recruiting

2024-517943-29-00 Pulmonary Hypertension associated with interstitial lun 5 2026-04-21
Visugromab in Cachexia International Trial Recruiting

2025-523533-25-00 Cancer-associated Cachexia 10 2026-03-26
A study to learn more about the change in the blood levels of transthyretin when participants with transthyretin amyloidosis with cardiomyop… Recruiting

2025-521831-35-00 Transthyretin Amyloid Cardiomyopathy (ATTR-CM) 6 2026-02-12
A study to investigate the effect of adding bleximenib to standard-of-care treatment with intensive chemotherapy in patients with a specific… Recruiting

2025-522767-15-00 Acute Myeloid Leukemia 5 2026-01-27
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL. Recruiting

2025-522052-13-00 Framework for Optimizing, Refining, and Unifying Manage 10 2025-12-24
A study to investigate the effect of adding venetoclax to treatment with ivosidenib and azacitidine in patients with acute myeloid leukemia … Recruiting

2024-512753-24-00 Acute Myeloid Leukemia (AML) 5 2025-08-05
International open-label phase I dose escalation study of dinutuximab beta in combination with vincristine/doxorubicin/cyclophosphamide and … Recruiting

2024-515245-42-00 Ewing Sarcoma 3 2025-04-24
IMPACT-AML: A RANDOMIZED PRAGMATIC CLINICAL TRIAL FOR RELAPSE OR REFRACTORY ACUTE MYELOID LEUKEMIA Recruiting

2024-514517-35-00 Acute myeloid leukemia 5 2025-02-27
Safety and efficacy of anakinra treatment for patients with persistent respiratory symptoms post acute covid and immune system activation: t… Recruiting

2023-508123-12-00 Post-Acute COVID Syndrome (PACS) 10 2023-11-03
A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Placebo-Controlled Phase 3 Followed by an Ope… Recruiting

2023-509672-42-00 GRIN-related neurodevelopmental disorder 5 2023-02-02
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients with P… Recruiting

2024-514617-35-00 Progressive forms of Multiple Sclerosis 4 2021-12-20
A Phase 1/2 First in Human Study of the Menin-MLL (KMT2A) Inhibitor KO-539 in Patients with Relapsed or Refractory Acute Myeloid Leukemia Recruiting

2023-510509-17-00 Relapsed and/or refractory Acute Myeloid Leukemia 7 2020-06-17
ALL SCTped 2012 FORUM - Allogeneic Stem Cell Transplantation in Children and Adolescents with Acute Lymphoblastic Leukaemia Recruiting

2024-512657-24-00 Acute Lymphoblastic Leukaemia 10 2014-03-27
A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosi… Recruiting

2025-521546-23-00 Secondary progressive multiple sclerosis 5 2026-04-21
A trial to learn how well AZD4144 works, how safe it is, and how it moves throughout the body over time in adults with acute kidney injury c… Recruiting

2025-522232-13-00 Sepsis-associated acute kidney injury (AKI) 4 2026-03-06
Randomized Evaluation of Treosulfan versus Melphalan conditioning fol-lowed by PTCY in Patients with AML and MDS undergoing allogeneic Trans… Recruiting

2023-507879-21-00 AML and MDS undergoing allogeneic Transplantation 4 2026-01-19
Registry and clinical trial comparing standard intensity and reduced intensity treatment in patients with AML or CLL who do not have residua… Recruiting

2024-512503-39-00 Arm A (AML): Newly diagnosed de novo Acute myeloid leuk 6 2025-12-19
An Open-Label Extension Study for Participants with PAH Who Have Previously Participated in a Clinical Trial with PF-07868489 Recruiting

2025-521155-23-00 Pulmonary Arterial Hypertension 4 2025-12-19
Nivolumab in combination with cisplatin and 5-fluorouracil as induction therapy in children and adults with EBV-positive nasopharyngeal carc… Recruiting

2022-500676-59-00 EBV-positive nasopharyngeal carcinoma 4 2025-12-18
A Phase 2b, Open-Label, Two-cohort Study of Subcutaneous Amivantamab in Combination with Lazertinib as First-Line Treatment, or Subcutaneous… Recruiting

2025-520730-28-00 Common EGFR-Mutated Locally Advanced or Metastatic Non- 4 2025-12-08